Kayne Anderson Rudnick Investment Management
MXCT icon

Kayne Anderson Rudnick Investment Management’s MaxCyte MXCT Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-95
Closed -$147 – 1012
2025
Q4 		$147 Hold
95
– – ﹤0.01% 997
2025
Q3 		$150 Hold
95
– – ﹤0.01% 1015
2025
Q2 		$207 Hold
95
– – ﹤0.01% 1058
2025
Q1 		$259 Hold
95
– – ﹤0.01% 934
2024
Q4 		$395 Hold
95
– – ﹤0.01% 951
2024
Q3 		$370 Hold
95
– – ﹤0.01% 950
2024
Q2 		$372 Hold
95
– – ﹤0.01% 939
2024
Q1 		$398 Buy
+95
New +$446 ﹤0.01% 923

Other funds holding MXCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM

Kayne Anderson Rudnick Investment Management's MXCT Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 95 shares — an estimated $147 sold.

Kayne Anderson Rudnick Investment Management first reported a position in MXCT in Q1 2024 and held it in 8 quarters. The position peaked at $398 in Q1 2024. 131 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 95 MaxCyte shares in Q1 2026, an estimated $147.
  • Kayne Anderson Rudnick Investment Management first reported a position in MaxCyte in Q1 2024 and held it in 8 quarters.
  • Kayne Anderson Rudnick Investment Management's MaxCyte position peaked at $398 in Q1 2024.
  • 131 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.